Clinical Trial Update: Effect of Short-term Oxygen During CPET in Pulmonary Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effect of short-term oxygen during CPET in pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiorespiratory Disease
• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Snippet

Sponsor: University of Zurich | Conditions: Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension, Chronic Cardiorespiratory Disease | Phase 2 | Status: COMPLETED